← Leaderboards
Marc L Peters-Golden
University Of Michigan At Ann Arbor
$18,470,174
Attributed
$18,916,408
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,916,408 · 7
By mechanism
R01$9,753,169 · 3
R35$6,502,791 · 1
P50$2,277,468 · 2
R56$382,980 · 1
Top collaborators
- Fernando J Martinez2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Leslie J Crofford$13,141,649
- David M Aronoff$10,002,603
- Akira Ono$12,390,224
- Yatrik M Shah$14,576,569
- Bethany B. Moore$23,110,401
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungInsightSignal TransductionDinoprostoneCyclic AmpCellsMediatingFibroblastsAlveolar MacrophagesRegulationProteinsLung DiseasesPulmonary FibrosisMacrophageMolecularProstaglandinsCyclic Amp-Dependent Protein KinasesFoundationsLipid MediatorPhenotypeCell TypeResistancePropertyNovel Therapeutic Intervention
Grant awards (40)
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis$936,000
R35 · FY2025 · HL · contact PI
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis$917,279
R35 · FY2024 · HL · contact PI
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis$936,000
R35 · FY2023 · HL · contact PI
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis$928,378
R35 · FY2022 · HL · contact PI
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis$928,378
R35 · FY2021 · HL · contact PI
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis$928,378
R35 · FY2020 · HL · contact PI
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis$928,378
R35 · FY2019 · HL · contact PI
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk$574,738
R01 · FY2018 · HL · contact PI
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk$577,781
R01 · FY2017 · HL · contact PI
Control of Fibroblast Function by Prostaglandin E2 and Plasminogen Activation$388,750
R01 · FY2017 · HL · contact PI
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk$565,260
R01 · FY2016 · HL · contact PI
Control of Fibroblast Function by Prostaglandin E2 and Plasminogen Activation$388,750
R01 · FY2016 · HL · contact PI
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk$501,268
R01 · FY2015 · HL · contact PI
Control of Fibroblast Function by Prostaglandin E2 and Plasminogen Activation$381,806
R01 · FY2015 · HL · contact PI
Control of Fibroblast Function by Prostaglandin E2 and Plasminogen Activation$393,484
R01 · FY2014 · HL · contact PI
Control of Fibroblast Function by Prostaglandin E2 and Plasminogen Activation$370,090
R01 · FY2013 · HL · contact PI
Prostanoids, Plasminogen Actication, and Personalized Therapeutics in IPF$446,234
P50 · FY2012 · HL · contact PI
Eicosanoids and lung macrophage antimicrobial mechanisms$379,150
R01 · FY2012 · HL · contact PI
Control of fibroblast function by prostaglandin E2 and plasminogen activation$375,913
R01 · FY2012 · HL · contact PI
Prostanoids, Plasminogen Actication, and Personalized Therapeutics in IPF$446,234
P50 · FY2011 · HL · contact PI
Eicosanoids and lung macrophage antimicrobial mechanisms$382,980
R01 · FY2011 · HL · contact PI
Control of fibroblast function by prostaglandin E2 and plasminogen activation$379,710
R01 · FY2011 · HL · contact PI
Eicosanoids and lung macrophage antimicrobial mechanisms$382,980
R01 · FY2010 · HL · contact PI
Control of fibroblast function by prostaglandin E2 and plasminogen activation$379,710
R01 · FY2010 · HL · contact PI
Eicosanoids and lung macrophage antimicrobial mechanisms$382,980
R01 · FY2009 · HL · contact PI
Control of fibroblast function by prostaglandin E2 and plasminogen activation$379,710
R01 · FY2009 · HL · contact PI
Eicosanoids and lung macrophage antimicrobial mechanisms$382,980
R56 · FY2008 · HL · contact PI
Eicosanoids and Lung Macrophage Antimicrobial Mechanisms$322,040
R01 · FY2007 · HL · contact PI
Eisosanoid imbalance in fibrotic lung disease$359,880
P50 · FY2006 · HL · contact PI
Eicosanoids and Lung Macrophage Antimicrobial Mechanisms$331,658
R01 · FY2006 · HL · contact PI
Eisosanoid imbalance in fibrotic lung disease$351,932
P50 · FY2005 · HL
Eicosanoids and Lung Macrophage Antimicrobial Mechanisms$339,639
R01 · FY2005 · HL
Eicosanoids and Lung Macrophage Antimicrobial Mechanisms$339,639
R01 · FY2004 · HL
EICOSANOIDS AND LUNG MACROPHAGE ANTIMICROBIAL MECHANISMS$302,000
R01 · FY2003 · HL
EICOSANOIDS AND LUNG MACROPHAGE ANTIMICROBIAL MECHANISMS$302,000
R01 · FY2002 · HL
Eisosanoid imbalance in fibrotic lung disease$208,827
P50 · FY2002 · HL
EICOSANOIDS AND LUNG MACROPHAGE ANTIMICROBIAL MECHANISMS$302,000
R01 · FY2001 · HL
DEFICIENT CYCLOOXYGENASE EXPRESSION IN IPF FIBROBLASTS$208,827
P50 · FY2001 · HL
EICOSANOIDS AND LUNG MACROPHAGE ANTIMICROBIAL MECHANISMS$329,133
R01 · FY2000 · HL
DEFICIENT CYCLOOXYGENASE EXPRESSION IN IPF FIBROBLASTS$255,534
P50 · FY2000 · HL